{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T13:03:30Z","timestamp":1795266210100,"version":"4.10.3"},"reference-count":240,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuroinflammation plays an important role in the pathogenesis of various central nervous system (CNS) diseases. The NLRP3 inflammasome is an important intracellular multiprotein complex composed of the innate immune receptor NLRP3, the adaptor protein ASC, and the protease caspase-1. The activation of the NLRP3 inflammasome can induce pyroptosis and the release of the proinflammatory cytokines IL-1\u03b2 and IL-18, thus playing a central role in immune and inflammatory responses. Recent studies have revealed that the NLRP3 inflammasome is activated in the brain to induce neuroinflammation, leading to further neuronal damage and functional impairment, and contributes to the pathological process of various neurological diseases, such as multiple sclerosis, Parkinson\u2019s disease, Alzheimer\u2019s disease, and stroke. In this review, we summarize the important role of the NLRP3 inflammasome in the pathogenesis of neuroinflammation and the pathological course of CNS diseases and discuss potential approaches to target the NLRP3 inflammasome for the treatment of CNS diseases.<\/jats:p>","DOI":"10.1038\/s41423-025-01275-w","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T23:28:43Z","timestamp":1741822123000},"page":"341-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":350,"title":["NLRP3 inflammasome in neuroinflammation and central nervous system diseases"],"prefix":"10.1038","volume":"22","author":[{"given":"Wen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3351-6420","authenticated-orcid":false,"given":"Rongbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"1275_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"1275_CR2","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1038\/s41380-023-02239-0","volume":"28","author":"J Yao","year":"2023","unstructured":"Yao J, Wang Z, Song W, Zhang Y. Targeting NLRP3 inflammasome for neurodegenerative disorders. Mol Psychiatry. 2023;28:4512\u201327.","journal-title":"Mol Psychiatry"},{"key":"1275_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160:62\u201373.","journal-title":"Cell"},{"key":"1275_CR4","doi-asserted-by":"publisher","first-page":"113852","DOI":"10.1016\/j.celrep.2024.113852","volume":"43","author":"BH Koller","year":"2024","unstructured":"Koller BH, Nguyen M, Snouwaert JN, Gabel CA, Ting JP. Species-specific NLRP3 regulation and its role in CNS autoinflammatory diseases. Cell Rep. 2024;43:113852.","journal-title":"Cell Rep."},{"key":"1275_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13578-024-01256-y","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang L, Tang Y, Huang P, Luo S, She Z, Peng H, et al. Role of NLRP3 inflammasome in central nervous system diseases. Cell Biosci. 2024;14:75.","journal-title":"Cell Biosci"},{"key":"1275_CR6","doi-asserted-by":"crossref","unstructured":"Zhang WJ, Chen SJ, Zhou SC, Wu SZ, Wang H. Inflammasomes and Fibrosis. Front Immunol. 2021;12:643149.","DOI":"10.3389\/fimmu.2021.643149"},{"key":"1275_CR7","doi-asserted-by":"publisher","first-page":"851169","DOI":"10.3389\/fimmu.2022.851169","volume":"13","author":"W Xu","year":"2022","unstructured":"Xu W, Huang Y. Regulation of inflammatory cell death by phosphorylation. Front Immunol. 2022;13:851169.","journal-title":"Front Immunol"},{"key":"1275_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"1275_CR9","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18:2114\u201327.","journal-title":"Cell Mol Immunol"},{"key":"1275_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He Y, Zeng MY, Yang D, Motro B, N\u00fa\u00f1ez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530:354\u20137.","journal-title":"Nature"},{"key":"1275_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"key":"1275_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"1275_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","volume":"180","author":"K Wang","year":"2020","unstructured":"Wang K, Sun Q, Zhong X, Zeng M, Zeng H, Shi X, et al. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell. 2020;180:941\u2013955.e20.","journal-title":"Cell"},{"key":"1275_CR14","doi-asserted-by":"publisher","first-page":"eabj3859","DOI":"10.1126\/sciimmunol.abj3859","volume":"6","author":"C Wang","year":"2021","unstructured":"Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, et al. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation. Sci Immunol. 2021;6:eabj3859.","journal-title":"Sci Immunol"},{"key":"1275_CR15","doi-asserted-by":"publisher","first-page":"108998","DOI":"10.1016\/j.celrep.2021.108998","volume":"35","author":"B Zhou","year":"2021","unstructured":"Zhou B, Abbott DW. Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases. Cell Rep. 2021;35:108998.","journal-title":"Cell Rep."},{"key":"1275_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","volume":"6","author":"M Jiang","year":"2020","unstructured":"Jiang M, Qi L, Li L, Li Y. The caspase-3\/GSDME signaling pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 2020;6:112.","journal-title":"Cell Death Discov"},{"key":"1275_CR17","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41556-024-01463-2","volume":"26","author":"B Zhou","year":"2024","unstructured":"Zhou B, Jiang ZH, Dai MR, Ai YL, Xiao L, Zhong CQ, et al. Full-length GSDME mediates pyroptosis independent from cleavage. Nat Cell Biol. 2024;26:1545\u201357.","journal-title":"Nat Cell Biol"},{"key":"1275_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41590-022-01386-w","volume":"24","author":"YY Chao","year":"2023","unstructured":"Chao YY, Puhach A, Frieser D, Arunkumar M, Lehner L, Seeholzer T, et al. Human T(H)17 cells engage gasdermin E pores to release IL-1\u03b1 on NLRP3 inflammasome activation. Nat Immunol. 2023;24:295\u2013308.","journal-title":"Nat Immunol"},{"key":"1275_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","volume":"19","author":"R Patani","year":"2023","unstructured":"Patani R, Hardingham GE, Liddelow SA. Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat Rev Neurol. 2023;19:395\u2013409.","journal-title":"Nat Rev Neurol"},{"key":"1275_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","volume":"154","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154:204\u201319.","journal-title":"Immunology"},{"key":"1275_CR21","doi-asserted-by":"publisher","first-page":"1439125","DOI":"10.3389\/fneur.2024.1439125","volume":"15","author":"Y Cantero-Fortiz","year":"2024","unstructured":"Cantero-Fortiz Y, Boada M. The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer\u2019s, and Parkinson\u2019s disease\u2019. Front Neurol. 2024;15:1439125.","journal-title":"Front Neurol"},{"key":"1275_CR22","doi-asserted-by":"crossref","unstructured":"Tastan B, Heneka MT. The impact of neuroinflammation on neuronal integrity. Immunol Rev. 2024;327:8\u201332.","DOI":"10.1111\/imr.13419"},{"key":"1275_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/biom14101204","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Huang Y, Cao Y, Yang J. Astrocyte-mediated neuroinflammation in neurological conditions. Biomolecules. 2024;14:1204.","journal-title":"Biomolecules"},{"key":"1275_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet S, Prinz M, van Loo G. Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med. 2019;25:112\u201323.","journal-title":"Trends Mol Med"},{"key":"1275_CR25","doi-asserted-by":"publisher","first-page":"9588","DOI":"10.3390\/ijms25179588","volume":"25","author":"S Theophanous","year":"2024","unstructured":"Theophanous S, Sargiannidou I, Kleopa KA. Glial cells as key regulators in neuroinflammatory mechanisms associated with multiple sclerosis. Int J Mol Sci. 2024;25:9588.","journal-title":"Int J Mol Sci"},{"key":"1275_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/brain\/awn109","volume":"132","author":"H Neumann","year":"2009","unstructured":"Neumann H, Kotter MR, Franklin RJ. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain. 2009;132:288\u201395.","journal-title":"Brain"},{"key":"1275_CR27","doi-asserted-by":"publisher","first-page":"10444","DOI":"10.1074\/jbc.M413863200","volume":"280","author":"H Takeuchi","year":"2005","unstructured":"Takeuchi H, Mizuno T, Zhang G, Wang J, Kawanokuchi J, Kuno R, et al. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem. 2005;280:10444\u201354.","journal-title":"J Biol Chem"},{"key":"1275_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1471-4159.2001.00075.x","volume":"76","author":"SW Barger","year":"2001","unstructured":"Barger SW, Basile AS. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem. 2001;76:846\u201354.","journal-title":"J Neurochem"},{"key":"1275_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"key":"1275_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02309-6","volume":"18","author":"SC Woodburn","year":"2021","unstructured":"Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation. 2021;18:258.","journal-title":"J Neuroinflammation"},{"key":"1275_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s11481-013-9480-6","volume":"8","author":"CJ Jensen","year":"2013","unstructured":"Jensen CJ, Massie A, De Keyser J. Immune players in the CNS: the astrocyte. J Neuroimmune Pharm. 2013;8:824\u201339.","journal-title":"J Neuroimmune Pharm"},{"key":"1275_CR32","doi-asserted-by":"publisher","first-page":"105080","DOI":"10.1016\/j.neuint.2021.105080","volume":"148","author":"YY Fan","year":"2021","unstructured":"Fan YY, Huo J. A1\/A2 astrocytes in central nervous system injuries and diseases: Angels or devils? Neurochem Int. 2021;148:105080.","journal-title":"Neurochem Int"},{"key":"1275_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"1275_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.arcmed.2021.11.002","volume":"53","author":"J Brown","year":"2022","unstructured":"Brown J, Everett C, Barragan JA, Vargas-Medrano J, Gadad BS, Nichols F, et al. Multiple sclerosis-associated bacterial ligand 654. Arch Med Res. 2022;53:157\u201362.","journal-title":"Arch Med Res"},{"key":"1275_CR35","doi-asserted-by":"publisher","first-page":"113476","DOI":"10.1016\/j.intimp.2024.113476","volume":"143","author":"Y Nan","year":"2024","unstructured":"Nan Y, Ni S, Liu M, Hu K. The emerging role of microglia in the development and therapy of multiple sclerosis. Int Immunopharmacol. 2024;143:113476.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9:42.","journal-title":"Transl Neurodegener"},{"key":"1275_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05551-3","volume":"14","author":"A Montilla","year":"2023","unstructured":"Montilla A, Zabala A, Er-Lukowiak M, Rissiek B, Magnus T, Rodriguez-Iglesias N, et al. Microglia and meningeal macrophages depletion delays the onset of experimental autoimmune encephalomyelitis. Cell Death Dis. 2023;14:16.","journal-title":"Cell Death Dis"},{"key":"1275_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-016-0343-2","volume":"4","author":"TY Chuang","year":"2016","unstructured":"Chuang TY, Guo Y, Seki SM, Rosen AM, Johanson DM, Mandell JW, et al. LRP1 expression in microglia is protective during CNS autoimmunity. Acta Neuropathol Commun. 2016;4:68.","journal-title":"Acta Neuropathol Commun"},{"key":"1275_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10787-018-0528-3","volume":"27","author":"T Grygorowicz","year":"2019","unstructured":"Grygorowicz T, Stru\u017cy\u0144ska L. Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis. Inflammopharmacology. 2019;27:129\u201337.","journal-title":"Inflammopharmacology"},{"key":"1275_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03084-7","volume":"11","author":"N Hagan","year":"2020","unstructured":"Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, et al. CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis. 2020;11:904.","journal-title":"Cell Death Dis"},{"key":"1275_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/ADR-200171","volume":"4","author":"B Sinyor","year":"2020","unstructured":"Sinyor B, Mineo J, Ochner C. Alzheimer\u2019s disease, inflammation, and the role of antioxidants. J Alzheimers Dis Rep. 2020;4:175\u201383.","journal-title":"J Alzheimers Dis Rep."},{"key":"1275_CR42","doi-asserted-by":"publisher","first-page":"102098","DOI":"10.1016\/j.arr.2023.102098","volume":"92","author":"S Kumari","year":"2023","unstructured":"Kumari S, Dhapola R, Sharma P, Singh SK, Reddy DH. Implicative role of cytokines in neuroinflammation mediated AD and associated signaling pathways: current Progress in molecular signaling and therapeutics. Aging Res Rev. 2023;92:102098.","journal-title":"Aging Res Rev"},{"key":"1275_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009;73:768\u201374.","journal-title":"Neurology"},{"key":"1275_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9:211.","journal-title":"Signal Transduct Target Ther"},{"key":"1275_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY Pang","year":"2019","unstructured":"Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang E, et al. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener. 2019;8:23.","journal-title":"Transl Neurodegener"},{"key":"1275_CR46","doi-asserted-by":"publisher","first-page":"11629","DOI":"10.3390\/ijms252111629","volume":"25","author":"N Dom\u00ednguez Rojo","year":"2024","unstructured":"Dom\u00ednguez Rojo N, Blanco Ben\u00edtez M, Cava R, Fuentes JM, Canales Cort\u00e9s S, Gonz\u00e1lez Polo RA. Convergence of neuroinflammation, microbiota, and parkinson\u2019s disease: therapeutic insights and prospects. Int J Mol Sci. 2024;25:11629.","journal-title":"Int J Mol Sci"},{"key":"1275_CR47","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators.","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol"},{"key":"1275_CR48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(16)30962-X","volume":"389","author":"GJ Hankey","year":"2017","unstructured":"Hankey GJ. Stroke. Lancet. 2017;389:641\u201354.","journal-title":"Lancet"},{"key":"1275_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1516-2","volume":"16","author":"RL Jayaraj","year":"2019","unstructured":"Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflamm. 2019;16:142.","journal-title":"J Neuroinflamm"},{"key":"1275_CR50","doi-asserted-by":"publisher","first-page":"e14853","DOI":"10.1111\/cns.14853","volume":"30","author":"P Jia","year":"2024","unstructured":"Jia P, Peng Q, Fan X, Zhang Y, Xu H, Li J, et al. Immune-mediated disruption of the blood\u2012brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets. CNS Neurosci Ther. 2024;30:e14853.","journal-title":"CNS Neurosci Ther"},{"key":"1275_CR51","doi-asserted-by":"publisher","first-page":"115023","DOI":"10.1016\/j.expneurol.2024.115023","volume":"383","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Gu H, Kong Y. Targeting PTEN in ischemic stroke: from molecular mechanisms to therapeutic potentials. Exp Neurol. 2024;383:115023.","journal-title":"Exp Neurol"},{"key":"1275_CR52","doi-asserted-by":"publisher","first-page":"16450","DOI":"10.1021\/acsnano.4c03425","volume":"18","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li Z, Fan X, Jiang C, Wang J, Rastegar-Kashkooli Y, et al. Nanozymes: potential therapies for reactive oxygen species overproduction and inflammation in ischemic stroke and traumatic brain injury. ACS Nano. 2024;18:16450\u201367.","journal-title":"ACS Nano"},{"key":"1275_CR53","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","volume":"18","author":"K Shi","year":"2019","unstructured":"Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18:1058\u201366.","journal-title":"Lancet Neurol"},{"key":"1275_CR54","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1177\/0271678X16666551","volume":"37","author":"M Li","year":"2017","unstructured":"Li M, Li Z, Ren H, Jin WN, Wood K, Liu Q, et al. Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2017;37:2383\u201395.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1275_CR55","first-page":"E396","volume":"114","author":"M Li","year":"2017","unstructured":"Li M, Li Z, Yao Y, Jin WN, Wood K, Liu Q, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci USA. 2017;114:E396\u2013e405.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1275_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","volume":"275","author":"JE Burda","year":"2016","unstructured":"Burda JE, Bernstein AM, Sofroniew MV. Astrocyte roles in traumatic brain injury. Exp Neurol. 2016;275:305\u201315.","journal-title":"Exp Neurol"},{"key":"1275_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-014-1355-2","volume":"129","author":"J Neumann","year":"2015","unstructured":"Neumann J, Riek-Burchardt M, Herz J, Doeppner TR, K\u00f6nig R, H\u00fctten H, et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol. 2015;129:259\u201377.","journal-title":"Acta Neuropathol"},{"key":"1275_CR58","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41423-022-00922-w","volume":"19","author":"A Akbal","year":"2022","unstructured":"Akbal A, Dernst A, Lovotti M, Mangan M, McManus RM, Latz E. How location and cellular signaling combine to activate the NLRP3 inflammasome. Cell Mol Immunol. 2022;19:1201\u201314.","journal-title":"Cell Mol Immunol"},{"key":"1275_CR59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22:550\u20139.","journal-title":"Nat Immunol"},{"key":"1275_CR60","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Res. 2015;25:1285\u201398.","journal-title":"Cell Res"},{"key":"1275_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s43556-024-00179-x","volume":"5","author":"Z Xu","year":"2024","unstructured":"Xu Z, Kombe Kombe AJ, Deng S, Zhang H, Wu S, Ruan J, et al. NLRP inflammasomes in health and disease. Mol Biomed. 2024;5:14.","journal-title":"Mol Biomed"},{"key":"1275_CR62","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","volume":"42","author":"L Chen","year":"2021","unstructured":"Chen L, Cao SQ, Lin ZM, He SJ, Zuo JP. NOD-like receptors in autoimmune diseases. Acta Pharm Sin. 2021;42:1742\u201356.","journal-title":"Acta Pharm Sin"},{"key":"1275_CR63","doi-asserted-by":"publisher","first-page":"101192","DOI":"10.1016\/j.arr.2020.101192","volume":"64","author":"YS Feng","year":"2020","unstructured":"Feng YS, Tan ZX, Wu LY, Dong F, Zhang F. The involvement of NLRP3 inflammasome in the treatment of Alzheimer\u2019s disease. Aging Res Rev. 2020;64:101192.","journal-title":"Aging Res Rev"},{"key":"1275_CR64","doi-asserted-by":"publisher","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","volume":"10","author":"R Gordon","year":"2018","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, et al. Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018;10:eaah4066.","journal-title":"Sci Transl Med"},{"key":"1275_CR65","doi-asserted-by":"publisher","first-page":"e13834","DOI":"10.1111\/acel.13834","volume":"22","author":"YQ Yan","year":"2023","unstructured":"Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, Xue NJ, et al. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson\u2019s disease. Aging Cell. 2023;22:e13834.","journal-title":"Aging Cell"},{"key":"1275_CR66","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N, Kam TI, Wang H, Neifert S, Chou SC, Kumar M, et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron. 2022;110:2422\u20132437.e9.","journal-title":"Neuron"},{"key":"1275_CR67","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","volume":"15","author":"X Han","year":"2019","unstructured":"Han X, Sun S, Sun Y, Song Q, Zhu J, Song N, et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Autophagy. 2019;15:1860\u201381.","journal-title":"Autophagy"},{"key":"1275_CR68","doi-asserted-by":"publisher","first-page":"111532","DOI":"10.1016\/j.celrep.2022.111532","volume":"41","author":"S Li","year":"2022","unstructured":"Li S, Fang Y, Zhang Y, Song M, Zhang X, Ding X, et al. Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice. Cell Rep. 2022;41:111532.","journal-title":"Cell Rep."},{"key":"1275_CR69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signaling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2024;23:43\u201366.","journal-title":"Nat Rev Drug Discov"},{"key":"1275_CR70","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1093\/brain\/awad045","volume":"146","author":"PY Chen","year":"2023","unstructured":"Chen PY, Yen JC, Liu TT, Chen ST, Wang SJ, Chen SP. Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation. Brain. 2023;146:2989\u20133002.","journal-title":"Brain"},{"key":"1275_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1498-0","volume":"16","author":"P Hong","year":"2019","unstructured":"Hong P, Gu RN, Li FX, Xiong XX, Liang WB, You ZJ, et al. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. J Neuroinflammation. 2019;16:121.","journal-title":"J Neuroinflammation"},{"key":"1275_CR72","doi-asserted-by":"publisher","first-page":"101522","DOI":"10.1016\/j.xcrm.2024.101522","volume":"5","author":"X Guan","year":"2024","unstructured":"Guan X, Zhu S, Song J, Liu K, Liu M, Xie L, et al. Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke. Cell Rep. Med. 2024;5:101522.","journal-title":"Cell Rep. Med"},{"key":"1275_CR73","doi-asserted-by":"publisher","first-page":"993168","DOI":"10.3389\/fimmu.2022.993168","volume":"13","author":"F Jiang","year":"2022","unstructured":"Jiang F, Xia M, Zhang Y, Chang J, Cao J, Zhang Z, et al. Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury. Front Immunol. 2022;13:993168.","journal-title":"Front Immunol"},{"key":"1275_CR74","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmet.2020.01.009","volume":"31","author":"M He","year":"2020","unstructured":"He M, Chiang HH, Luo H, Zheng Z, Qiao Q, Wang L, et al. An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance. Cell Metab. 2020;31:580\u2013591.e5.","journal-title":"Cell Metab"},{"key":"1275_CR75","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes nonphlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun. 2017;61:306\u201316.","journal-title":"Brain Behav Immun"},{"key":"1275_CR76","doi-asserted-by":"publisher","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","volume":"928","author":"H Li","year":"2022","unstructured":"Li H, Guan Y, Liang B, Ding P, Hou X, Wei W, et al. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome. Eur J Pharm. 2022;928:175091.","journal-title":"Eur J Pharm"},{"key":"1275_CR77","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/jnnp.67.6.785","volume":"67","author":"R Furlan","year":"1999","unstructured":"Furlan R, Filippi M, Bergami A, Rocca MA, Martinelli V, Poliani PL, et al. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study. J Neurol Neurosurg Psychiatry. 1999;67:785\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1275_CR78","doi-asserted-by":"publisher","first-page":"15811","DOI":"10.1523\/JNEUROSCI.4088-10.2010","volume":"30","author":"S Jha","year":"2010","unstructured":"Jha S, Srivastava SY, Brickey WJ, Iocca H, Toews A, Morrison JP, et al. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci. 2010;30:15811\u201320.","journal-title":"J Neurosci"},{"key":"1275_CR79","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4049\/jimmunol.0904145","volume":"185","author":"D Gris","year":"2010","unstructured":"Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol. 2010;185:974\u201381.","journal-title":"J Immunol"},{"key":"1275_CR80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/iji.12401","volume":"45","author":"D Imani","year":"2018","unstructured":"Imani D, Azimi A, Salehi Z, Rezaei N, Emamnejad R, Sadr M, et al. Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing-remitting multiple sclerosis. Int J Immunogenet. 2018;45:329\u201336.","journal-title":"Int J Immunogenet"},{"key":"1275_CR81","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1073\/pnas.1201836109","volume":"109","author":"M Inoue","year":"2012","unstructured":"Inoue M, Williams KL, Gunn MD, Shinohara ML. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2012;109:10480\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1275_CR82","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1172\/JCI121901","volume":"128","author":"CJ Zhang","year":"2018","unstructured":"Zhang CJ, Jiang M, Zhou H, Liu W, Wang C, Kang Z, et al. TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation. J Clin Invest. 2018;128:5399\u2013412.","journal-title":"J Clin Invest"},{"key":"1275_CR83","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/brain\/awaa084","volume":"143","author":"S Malhotra","year":"2020","unstructured":"Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Mart\u00ednez-Banaclocha H, et al. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain. 2020;143:1414\u201330.","journal-title":"Brain"},{"key":"1275_CR84","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.neuron.2022.07.015","volume":"110","author":"Z Sun","year":"2022","unstructured":"Sun Z, Zhao H, Fang D, Davis CT, Shi DS, Lei K, et al. Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling. Neuron. 2022;110:3106\u2013312.e7.","journal-title":"Neuron"},{"key":"1275_CR85","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.immuni.2020.01.002","volume":"52","author":"AM McGinley","year":"2020","unstructured":"McGinley AM, Sutton CE, Edwards SC, Leane CM, DeCourcey J, Teijeiro A, et al. Interleukin-17A serves a priming role in autoimmunity by recruiting IL-1\u03b2-producing myeloid cells that promote pathogenic T cells. Immunity. 2020;52:342\u2013356.e6.","journal-title":"Immunity"},{"key":"1275_CR86","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/s41423-020-00589-1","volume":"18","author":"G Yang","year":"2021","unstructured":"Yang G, Song W, Xu J, Postoak JL, Cheng F, Martinez J, et al. Pik3c3 deficiency in myeloid cells imparts partial resistance to experimental autoimmune encephalomyelitis associated with reduced IL-1\u03b2 production. Cell Mol Immunol. 2021;18:2024\u201339.","journal-title":"Cell Mol Immunol"},{"key":"1275_CR87","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","volume":"20","author":"F Stocchi","year":"2024","unstructured":"Stocchi F, Bravi D, Emmi A, Antonini A. Parkinson disease therapy: current strategies and future research priorities. Nat Rev Neurol. 2024;20:695\u2013707.","journal-title":"Nat Rev Neurol"},{"key":"1275_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1670-6","volume":"17","author":"Z Fan","year":"2020","unstructured":"Fan Z, Pan YT, Zhang ZY, Yang H, Yu SY, Zheng Y, et al. Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease. J Neuroinflamm. 2020;17:11.","journal-title":"J Neuroinflamm"},{"key":"1275_CR89","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-020-00147-6","volume":"7","author":"FL Anderson","year":"2021","unstructured":"Anderson FL, von Herrmann KM, Andrew AS, Kuras YI, Young AL, Scherzer CR, et al. Plasma-borne indicators of inflammasome activity in Parkinson\u2019s disease patients. NPJ Parkinsons Dis. 2021;7:2.","journal-title":"NPJ Parkinsons Dis"},{"key":"1275_CR90","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E, Hwang I, Park S, Hong S, Hwang B, Cho Y, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ. 2019;26:213\u201328.","journal-title":"Cell Death Differ"},{"key":"1275_CR91","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fncel.2014.00216","volume":"8","author":"S Alfonso-Loeches","year":"2014","unstructured":"Alfonso-Loeches S, Ure\u00f1a-Peralta JR, Morillo-Bargues MJ, Oliver-De La Cruz J, Guerri C. Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells. Front Cell Neurosci. 2014;8:216.","journal-title":"Front Cell Neurosci"},{"key":"1275_CR92","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1007\/s12035-016-9980-5","volume":"54","author":"C Qiao","year":"2017","unstructured":"Qiao C, Zhang LX, Sun XY, Ding JH, Lu M, Hu G. Caspase-1 deficiency alleviates dopaminergic neuronal death via inhibiting caspase-7\/AIF pathway in MPTP\/p mouse model of Parkinson\u2019s disease. Mol Neurobiol. 2017;54:4292\u2013302.","journal-title":"Mol Neurobiol"},{"key":"1275_CR93","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s11064-017-2185-0","volume":"42","author":"Z Mao","year":"2017","unstructured":"Mao Z, Liu C, Ji S, Yang Q, Ye H, Han H, et al. The NLRP3 inflammasome is involved in the pathogenesis of Parkinson\u2019s disease in rats. Neurochem Res. 2017;42:1104\u201315.","journal-title":"Neurochem Res"},{"key":"1275_CR94","doi-asserted-by":"publisher","first-page":"105651","DOI":"10.1016\/j.intimp.2019.05.036","volume":"75","author":"C Yang","year":"2019","unstructured":"Yang C, Mo Y, Xu E, Wen H, Wei R, Li S, et al. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration by inhibiting neuroinflammation and oxidative stress in a Parkinson\u2019s disease mouse model. Int Immunopharmacol. 2019;75:105651.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR95","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","volume":"91","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Kwatra M, Ranjan Panda S, Murty U, Naidu V. Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in vitro and in vivo models of Parkinson disease. Brain Behav Immun. 2021;91:142\u201358.","journal-title":"Brain Behav Immun"},{"key":"1275_CR96","doi-asserted-by":"publisher","first-page":"107912","DOI":"10.1016\/j.bioorg.2024.107912","volume":"153","author":"T Tantra","year":"2024","unstructured":"Tantra T, Rahaman T A A, Nandini, Chaudhary S. Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer\u2019s disease. Bioorg Chem. 2024;153:107912.","journal-title":"Bioorg Chem"},{"key":"1275_CR97","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H. Alzheimer\u2019s disease. Lancet. 2006;368:387\u2013403.","journal-title":"Lancet"},{"key":"1275_CR98","doi-asserted-by":"publisher","first-page":"109941","DOI":"10.1016\/j.neuropharm.2024.109941","volume":"252","author":"RM McManus","year":"2024","unstructured":"McManus RM, Latz E. NLRP3 inflammasome signaling in Alzheimer\u2019s disease. Neuropharmacology. 2024;252:109941.","journal-title":"Neuropharmacology"},{"key":"1275_CR99","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669\u201373.","journal-title":"Nature"},{"key":"1275_CR100","doi-asserted-by":"publisher","first-page":"1471005","DOI":"10.3389\/fncel.2024.1471005","volume":"18","author":"W Quan","year":"2024","unstructured":"Quan W, Decker Y, Luo Q, Chemla A, Chang HF, Li D, et al. Deficiency of NLRP3 protects cerebral pericytes and attenuates Alzheimer\u2019s pathology in tau-transgenic mice. Front Cell Neurosci. 2024;18:1471005.","journal-title":"Front Cell Neurosci"},{"key":"1275_CR101","doi-asserted-by":"publisher","first-page":"e02063","DOI":"10.1002\/brb3.2063","volume":"11","author":"H Shen","year":"2021","unstructured":"Shen H, Han C, Yang Y, Guo L, Sheng Y, Wang J, et al. Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer\u2019s disease. Brain Behav. 2021;11:e02063.","journal-title":"Brain Behav"},{"key":"1275_CR102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","volume":"11","author":"M Saresella","year":"2016","unstructured":"Saresella M, La Rosa F, Piancone F, Zoppis M, Marventano I, Calabrese E, et al. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease. Mol Neurodegener. 2016;11:23.","journal-title":"Mol Neurodegener"},{"key":"1275_CR103","doi-asserted-by":"publisher","first-page":"eabb8680","DOI":"10.1126\/sciadv.abb8680","volume":"6","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K, et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer\u2019s disease. Sci Adv. 2020;6:eabb8680.","journal-title":"Sci Adv"},{"key":"1275_CR104","doi-asserted-by":"publisher","first-page":"2101166","DOI":"10.1002\/adbi.202101166","volume":"6","author":"RM McManus","year":"2022","unstructured":"McManus RM. The role of immunity in Alzheimer\u2019s disease. Adv Biol (Weinh). 2022;6:2101166.","journal-title":"Adv Biol (Weinh)"},{"key":"1275_CR105","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"1275_CR106","first-page":"3574","volume":"168","author":"D Jha","year":"2024","unstructured":"Jha D, Bakker E, Kumar R. Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer\u2019s disease. J Neurochem. 2024;168:3574\u201398.","journal-title":"J Neurochem"},{"key":"1275_CR107","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"1275_CR108","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","volume":"30","author":"LL Friker","year":"2020","unstructured":"Friker LL, Scheiblich H, Hochheiser IV, Brinkschulte R, Riedel D, Latz E, et al. \u03b2-amyloid clustering around ASC fibrils boosts its toxicity in microglia. Cell Rep. 2020;30:3743\u20133754.e6.","journal-title":"Cell Rep."},{"key":"1275_CR109","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/jnc.14945","volume":"155","author":"A Lu\u010di\u016bnait\u0117","year":"2020","unstructured":"Lu\u010di\u016bnait\u0117 A, McManus RM, Jankunec M, R\u00e1cz I, Dansokho C, Dalg\u0117dien\u0117 I, et al. Soluble A\u03b2 oligomers and protofibrils induce NLRP3 inflammasome activation in microglia. J Neurochem. 2020;155:650\u201361.","journal-title":"J Neurochem"},{"key":"1275_CR110","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and nonexogenously seeded Tau pathology in vivo. Acta Neuropathol. 2019;137:599\u2013617.","journal-title":"Acta Neuropathol"},{"key":"1275_CR111","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD, Vasilevko V, et al. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model. J Immunol. 2011;187:6539\u201349.","journal-title":"J Immunol"},{"key":"1275_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02099-x","volume":"18","author":"AF Batista","year":"2021","unstructured":"Batista AF, Rody T, Forny-Germano L, Cerdeiro S, Bellio M, Ferreira ST, et al. Interleukin-1\u03b2 mediates alterations in mitochondrial fusion\/fission proteins and memory impairment induced by amyloid-\u03b2 oligomers. J Neuroinflammation. 2021;18:54.","journal-title":"J Neuroinflammation"},{"key":"1275_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06449-x","volume":"9","author":"J Flores","year":"2018","unstructured":"Flores J, No\u00ebl A, Foveau B, Lynham J, Lecrux C, LeBlanc AC. Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer\u2019s disease mouse model. Nat Commun. 2018;9:3916.","journal-title":"Nat Commun"},{"key":"1275_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05290-x","volume":"13","author":"J Flores","year":"2022","unstructured":"Flores J, Fillion ML, LeBlanc AC. Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice. Cell Death Dis. 2022;13:864.","journal-title":"Cell Death Dis"},{"key":"1275_CR115","doi-asserted-by":"publisher","unstructured":"Cheng F, Yan B, Liao P, Gao H, Yin Z, Li D, et al. Ischemic stroke and the biological hallmarks of aging. Aging Dis. 2024 https:\/\/doi.org\/10.14336\/AD.2024.01059.","DOI":"10.14336\/AD.2024.01059"},{"key":"1275_CR116","doi-asserted-by":"publisher","first-page":"e70114","DOI":"10.1111\/cns.70114","volume":"30","author":"X Chen","year":"2024","unstructured":"Chen X, Yang DX, Zhao H, Zhang HF, Hong P. Stroke-induced renal dysfunction: underlying mechanisms and challenges of the brain-kidney Axis. CNS Neurosci Ther. 2024;30:e70114.","journal-title":"CNS Neurosci Ther"},{"key":"1275_CR117","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbi.2020.12.009","volume":"92","author":"M Franke","year":"2021","unstructured":"Franke M, Bieber M, Kraft P, Weber A, Stoll G, Schuhmann MK. The NLRP3 inflammasome drives inflammation in ischemia\/reperfusion injury after transient middle cerebral artery occlusion in mice. Brain Behav Immun. 2021;92:223\u201333.","journal-title":"Brain Behav Immun"},{"key":"1275_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.326","volume":"4","author":"DY Fann","year":"2013","unstructured":"Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 2013;4:e790.","journal-title":"Cell Death Dis"},{"key":"1275_CR119","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/jcbfm.2013.242","volume":"34","author":"F Yang","year":"2014","unstructured":"Yang F, Wang Z, Wei X, Han H, Meng X, Zhang Y, et al. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J Cereb Blood Flow Metab. 2014;34:660\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1275_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24350-x","volume":"8","author":"S Ismael","year":"2018","unstructured":"Ismael S, Zhao L, Nasoohi S, Ishrat T. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8:5971.","journal-title":"Sci Rep."},{"key":"1275_CR121","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/bph.15732","volume":"179","author":"A Palomino-Antolin","year":"2022","unstructured":"Palomino-Antolin A, Narros-Fern\u00e1ndez P, Farr\u00e9-Alins V, Sevilla-Montero J, Decouty-P\u00e9rez C, Lopez-Rodriguez AB, et al. Time-dependent dual effect of NLRP3 inflammasome in brain ischemia. Br J Pharm. 2022;179:1395\u2013410.","journal-title":"Br J Pharm"},{"key":"1275_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01988-x","volume":"17","author":"R Sun","year":"2020","unstructured":"Sun R, Peng M, Xu P, Huang F, Xie Y, Li J, et al. Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia\/reperfusion injury. J Neuroinflamm. 2020;17:330.","journal-title":"J Neuroinflamm"},{"key":"1275_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8360","volume":"6","author":"M Ito","year":"2015","unstructured":"Ito M, Shichita T, Okada M, Komine R, Noguchi Y, Yoshimura A, et al. Bruton\u2019s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischemic brain injury. Nat Commun. 2015;6:7360.","journal-title":"Nat Commun"},{"key":"1275_CR124","doi-asserted-by":"publisher","first-page":"1552127","DOI":"10.1155\/2021\/1552127","volume":"2021","author":"Y Ran","year":"2021","unstructured":"Ran Y, Su W, Gao F, Ding Z, Yang S, Ye L, et al. Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia\/Macrophage Pyroptosis through NF-\u03baB Suppression and NLRP3 Inflammasome Inhibition. Oxid Med Cell Longev. 2021;2021:1552127.","journal-title":"Oxid Med Cell Longev"},{"key":"1275_CR125","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.intimp.2016.09.024","volume":"40","author":"J Qiu","year":"2016","unstructured":"Qiu J, Wang M, Zhang J, Cai Q, Lu D, Li Y, et al. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling. Int Immunopharmacol. 2016;40:492\u2013500.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR126","doi-asserted-by":"publisher","first-page":"370530","DOI":"10.1155\/2014\/370530","volume":"2014","author":"N Zhang","year":"2014","unstructured":"Zhang N, Zhang X, Liu X, Wang H, Xue J, Yu J, et al. Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia\/reperfusion in mice. Mediators Inflamm. 2014;2014:370530.","journal-title":"Mediators Inflamm"},{"key":"1275_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02492-0","volume":"19","author":"H Wang","year":"2022","unstructured":"Wang H, He Y, Sun Z, Ren S, Liu M, Wang G, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflamm. 2022;19:132.","journal-title":"J Neuroinflamm"},{"key":"1275_CR128","doi-asserted-by":"publisher","first-page":"106625","DOI":"10.1016\/j.phrs.2022.106625","volume":"187","author":"CY Xia","year":"2023","unstructured":"Xia CY, Guo YX, Lian WW, Yan Y, Ma BZ, Cheng YC, et al. The NLRP3 inflammasome in depression: potential mechanisms and therapies. Pharm Res. 2023;187:106625.","journal-title":"Pharm Res"},{"key":"1275_CR129","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2024.03.029","volume":"546","author":"J Chen","year":"2024","unstructured":"Chen J, Gao Y, Liu N, Hai D, Wei W, Liu Y, et al. Mechanism of NLRP3 inflammasome in epilepsy and related therapeutic agents. Neuroscience. 2024;546:157\u201377.","journal-title":"Neuroscience"},{"key":"1275_CR130","doi-asserted-by":"publisher","first-page":"E538","DOI":"10.1503\/jpn.210016","volume":"46","author":"GN Pandey","year":"2021","unstructured":"Pandey GN, Zhang H, Sharma A, Ren X. Innate immunity receptors in depression and suicide: upregulated NOD-like receptors containing pyrin (NLRPs) and hyperactive inflammasomes in the postmortem brains of people who were depressed and died by suicide. J Psychiatry Neurosci. 2021;46:E538\u2013e547.","journal-title":"J Psychiatry Neurosci"},{"key":"1275_CR131","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12031-019-01401-0","volume":"70","author":"A Taene","year":"2020","unstructured":"Taene A, Khalili-Tanha G, Esmaeili A, Mobasheri L, Kooshkaki O, Jafari S, et al. The association of major depressive disorder with activation of NLRP3 inflammasome, lipid peroxidation, and total antioxidant capacity. J Mol Neurosci. 2020;70:65\u201370.","journal-title":"J Mol Neurosci"},{"key":"1275_CR132","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/bcpt.12604","volume":"119","author":"C Sahin","year":"2016","unstructured":"Sahin C, Albayrak O, Akdeniz TF, Akbulut Z, Yanikkaya Demirel G, Aricioglu F. Agmatine reverses subchronic stress induced nod-like receptor protein 3 (NLRP3) activation and cytokine response in rats. Basic Clin Pharm Toxicol. 2016;119:367\u201375.","journal-title":"Basic Clin Pharm Toxicol"},{"key":"1275_CR133","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11011-018-0342-z","volume":"34","author":"W Gao","year":"2019","unstructured":"Gao W, Wang W, Liu G, Zhang J, Yang J, Deng Z. Allicin attenuated chronic social defeat stress induced depressive-like behaviors through suppression of NLRP3 inflammasome. Metab Brain Dis. 2019;34:319\u201329.","journal-title":"Metab Brain Dis"},{"key":"1275_CR134","doi-asserted-by":"publisher","first-page":"BSR20200672","DOI":"10.1042\/BSR20200672","volume":"40","author":"J Zhu","year":"2020","unstructured":"Zhu J, Tang J. LncRNA Gm14205 induces astrocytic NLRP3 inflammasome activation by inhibiting oxytocin receptor in postpartum depression. Biosci Rep. 2020;40:BSR20200672.","journal-title":"Biosci Rep."},{"key":"1275_CR135","doi-asserted-by":"publisher","first-page":"108560","DOI":"10.1016\/j.intimp.2022.108560","volume":"105","author":"X Zhai","year":"2022","unstructured":"Zhai X, Chen Y, Han X, Zhu Y, Li X, Zhang Y, et al. The protective effect of hypericin on postpartum depression rat model by inhibiting the NLRP3 inflammasome activation and regulating glucocorticoid metabolism. Int Immunopharmacol. 2022;105:108560.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR136","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1007\/s12035-018-1458-1","volume":"56","author":"E Trojan","year":"2019","unstructured":"Trojan E, Chamera K, Bryniarska N, Kotarska K, Le\u015bkiewicz M, Regulska M, et al. Role of chronic administration of antidepressant drugs in the prenatal stress-evoked inflammatory response in the brain of adult offspring rats: involvement of the NLRP3 inflammasome-related pathway. Mol Neurobiol. 2019;56:5365\u201380.","journal-title":"Mol Neurobiol"},{"key":"1275_CR137","doi-asserted-by":"publisher","first-page":"814828","DOI":"10.3389\/fpsyt.2022.814828","volume":"13","author":"XJ Yang","year":"2022","unstructured":"Yang XJ, Zhao BC, Li J, Shi C, Song YQ, Gao XZ, et al. Serum NLRP3 inflammasome and BDNF: potential biomarkers differentiating reactive and endogenous depression. Front Psychiatry. 2022;13:814828.","journal-title":"Front Psychiatry"},{"key":"1275_CR138","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1007\/s12035-015-9408-7","volume":"53","author":"E Alcocer-G\u00f3mez","year":"2016","unstructured":"Alcocer-G\u00f3mez E, Ulecia-Mor\u00f3n C, Mar\u00edn-Aguilar F, Rybkina T, Casas-Barquero N, Ruiz-Cabello J, et al. Stress-induced depressive behaviors require a functional NLRP3 inflammasome. Mol Neurobiol. 2016;53:4874\u201382.","journal-title":"Mol Neurobiol"},{"key":"1275_CR139","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.phrs.2017.04.028","volume":"121","author":"E Alcocer-G\u00f3mez","year":"2017","unstructured":"Alcocer-G\u00f3mez E, Casas-Barquero N, Williams MR, Romero-Guillena SL, Ca\u00f1adas-Lozano D, Bull\u00f3n P, et al. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder. Pharm Res. 2017;121:114\u201321.","journal-title":"Pharm Res"},{"key":"1275_CR140","doi-asserted-by":"publisher","first-page":"108488","DOI":"10.1016\/j.intimp.2021.108488","volume":"104","author":"K Abu-Elfotuh","year":"2022","unstructured":"Abu-Elfotuh K, Al-Najjar AH, Mohammed AA, Aboutaleb AS, Badawi GA. Fluoxetine ameliorates Alzheimer\u2019s disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2\/HO-1 and hindering TLR4\/NLRP3 inflammasome signaling pathway. Int Immunopharmacol. 2022;104:108488.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01842-0","volume":"17","author":"Y Dong","year":"2020","unstructured":"Dong Y, Li S, Lu Y, Li X, Liao Y, Peng Z, et al. Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice. J Neuroinflamm. 2020;17:205.","journal-title":"J Neuroinflamm"},{"key":"1275_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02744-7","volume":"20","author":"Z Qin","year":"2023","unstructured":"Qin Z, Shi DD, Li W, Cheng D, Zhang YD, Zhang S, et al. Berberine ameliorates depression-like behaviors in mice by inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption. J Neuroinflamm. 2023;20:54.","journal-title":"J Neuroinflamm"},{"key":"1275_CR143","doi-asserted-by":"publisher","first-page":"117587","DOI":"10.1016\/j.cca.2023.117587","volume":"551","author":"J Yang","year":"2023","unstructured":"Yang J, Li Y, Luo H, Ma J, Zheng Y, Zhou L, et al. Elevated serum levels of the NLRP3 inflammasome are associated with the severity of anti-NMDAR encephalitis in children. Clin Chim Acta. 2023;551:117587.","journal-title":"Clin Chim Acta"},{"key":"1275_CR144","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3389\/fimmu.2019.00905","volume":"10","author":"Y Peng","year":"2019","unstructured":"Peng Y, Liu B, Pei S, Zheng D, Wang Z, Ji T, et al. Higher CSF levels of NLRP3 inflammasome is associated with poor prognosis of anti-N-methyl-D-aspartate receptor encephalitis. Front Immunol. 2019;10:905.","journal-title":"Front Immunol"},{"key":"1275_CR145","doi-asserted-by":"publisher","first-page":"112374","DOI":"10.1016\/j.intimp.2024.112374","volume":"137","author":"X Yang","year":"2024","unstructured":"Yang X, Sun A, Kong L, Yang X, Zhao X, Wang S. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization. Int Immunopharmacol. 2024;137:112374.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02482-2","volume":"19","author":"Z Qin","year":"2022","unstructured":"Qin Z, Song J, Lin A, Yang W, Zhang W, Zhong F, et al. GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome. J Neuroinflamm. 2022;19:121.","journal-title":"J Neuroinflamm."},{"key":"1275_CR147","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/1567202616666181122165540","volume":"15","author":"K Shen","year":"2018","unstructured":"Shen K, Mao Q, Yin X, Zhang C, Jin Y, Deng A, et al. NLRP3 inflammasome activation leads to epileptic neuronal apoptosis. Curr Neurovasc Res. 2018;15:276\u201381.","journal-title":"Curr Neurovasc Res"},{"key":"1275_CR148","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/fcp.12689","volume":"35","author":"F Aghaie","year":"2021","unstructured":"Aghaie F, Moradifar F, Hosseini A. Rapamycin attenuates depression and anxiety-like behaviors through modulation of the NLRP3 pathway in pentylenetetrazole-kindled male Wistar rats. Fundam Clin Pharm. 2021;35:1045\u201354.","journal-title":"Fundam Clin Pharm"},{"key":"1275_CR149","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainresbull.2022.10.002","volume":"191","author":"A Samadianzakaria","year":"2022","unstructured":"Samadianzakaria A, Abdolmaleki Z, Faedmaleki F. The effect of valproic acid and furosemide on the regulation of the inflammasome complex (NLRP1 and NLRP3 mRNA) in the brain of epileptic animal model. Brain Res Bull. 2022;191:20\u201329.","journal-title":"Brain Res Bull"},{"key":"1275_CR150","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707\u201335.","journal-title":"Annu Rev Immunol"},{"key":"1275_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11929","volume":"7","author":"MS Dick","year":"2016","unstructured":"Dick MS, Sborgi L, R\u00fchl S, Hiller S, Broz P. ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat Commun. 2016;7:11929.","journal-title":"Nat Commun"},{"key":"1275_CR152","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI0216112","volume":"110","author":"T Ma","year":"2002","unstructured":"Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110:1651\u20138.","journal-title":"J Clin Invest"},{"key":"1275_CR153","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang H, He H, Chen Y, Huang W, Cheng J, Ye J, et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med. 2017;214:3219\u201338.","journal-title":"J Exp Med"},{"key":"1275_CR154","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/1874467213666200810140749","volume":"14","author":"K Shen","year":"2021","unstructured":"Shen K, Jiang W, Zhang C, Cai L, Wang Q, Yu H, et al. Molecular mechanism of a specific NLRP3 inhibitor to alleviate seizure severity induced by pentylenetetrazole. Curr Mol Pharm. 2021;14:579\u201386.","journal-title":"Curr Mol Pharm"},{"key":"1275_CR155","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/antiox12030722","volume":"12","author":"S Han","year":"2023","unstructured":"Han S, He Z, Hu X, Li X, Zheng K, Huang Y, et al. Inhibiting NLRP3 inflammasome activation by CY-09 helps to restore cerebral glucose metabolism in 3\u00d7Tg-AD mice. Antioxid (Basel). 2023;12:722.","journal-title":"Antioxid (Basel)"},{"key":"1275_CR156","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1021\/acschemneuro.2c00348","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Liu YJ, Zhang MM, Zhou H, Gao YH, Cheng WJ, et al. CY-09 alleviates the depression-like behaviors via inhibiting NLRP3 inflammasome-mediated neuroinflammation in lipopolysaccharide-induced mice. ACS Chem Neurosci. 2022;13:3291\u2013302.","journal-title":"ACS Chem Neurosci"},{"key":"1275_CR157","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556\u20139.","journal-title":"Nat Chem Biol"},{"key":"1275_CR158","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","volume":"43","author":"D Wu","year":"2020","unstructured":"Wu D, Chen Y, Sun Y, Gao Q, Li H, Yang Z, et al. Target of MCC950 in inhibition of NLRP3 inflammasome activation: a literature review. Inflammation. 2020;43:17\u201323.","journal-title":"Inflammation"},{"key":"1275_CR159","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248\u201355.","journal-title":"Nat Med"},{"key":"1275_CR160","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/1871527319666201005170659","volume":"20","author":"N He","year":"2021","unstructured":"He N, Zheng X, He T, Shen G, Wang K, Hu J, et al. MCC950 reduces neuronal apoptosis in spinal cord injury in mice. CNS Neurol Disord Drug Targets. 2021;20:298\u2013308.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1275_CR161","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","volume":"116","author":"A Naeem","year":"2024","unstructured":"Naeem A, Prakash R, Kumari N, Ali Khan M, Quaiyoom Khan A, Uddin S, et al. MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer\u2019s disease. Brain Behav Immun. 2024;116:70\u201384.","journal-title":"Brain Behav Immun"},{"key":"1275_CR162","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2019.01.035","volume":"142","author":"R Ward","year":"2019","unstructured":"Ward R, Li W, Abdul Y, Jackson L, Dong G, Jamil S, et al. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharm Res. 2019;142:237\u201350.","journal-title":"Pharm Res"},{"key":"1275_CR163","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T, et al. OLT1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci USA. 2018;115:E1530\u2013E1539.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1275_CR164","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","volume":"10","author":"A S\u00e1nchez-Fern\u00e1ndez","year":"2019","unstructured":"S\u00e1nchez-Fern\u00e1ndez A, Skouras DB, Dinarello CA, L\u00f3pez-Vales R. OLT1177 (dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis. Front Immunol. 2019;10:2578.","journal-title":"Front Immunol"},{"key":"1275_CR165","doi-asserted-by":"publisher","first-page":"111869","DOI":"10.1016\/j.intimp.2024.111869","volume":"131","author":"M Fang","year":"2024","unstructured":"Fang M, Xia F, Wang J, Wang C, Teng B, You S, et al. The NLRP3 inhibitor, OLT1177 attenuates brain injury in experimental intracerebral hemorrhage. Int Immunopharmacol. 2024;131:111869.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR166","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D'Alessandro A, et al. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2020;117:32145\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1275_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02830-w","volume":"20","author":"J Amo-Aparicio","year":"2023","unstructured":"Amo-Aparicio J, Daly J, H\u00f8jen JF, Dinarello CA. Pharmacologic inhibition of NLRP3 reduces the levels of \u03b1-synuclein and protects dopaminergic neurons in a model of Parkinson\u2019s disease. J Neuroinflamm. 2023;20:147.","journal-title":"J Neuroinflamm"},{"key":"1275_CR168","doi-asserted-by":"publisher","first-page":"106062","DOI":"10.1016\/j.isci.2023.106062","volume":"26","author":"Y Huang","year":"2023","unstructured":"Huang Y, Guo Y, Zhou Y, Huang Q, Ru Y, Luo Y, et al. Tivantinib alleviates inflammatory diseases by directly targeting NLRP3. iScience. 2023;26:106062.","journal-title":"iScience"},{"key":"1275_CR169","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fphar.2017.00459","volume":"8","author":"N Irrera","year":"2017","unstructured":"Irrera N, Pizzino G, Cal\u00f2 M, Pallio G, Mannino F, Fam\u00e0 F, et al. Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury. Front Pharm. 2017;8:459.","journal-title":"Front Pharm"},{"key":"1275_CR170","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.18632\/aging.102017","volume":"11","author":"Y Ruan","year":"2019","unstructured":"Ruan Y, Qiu X, Lv YD, Dong D, Wu XJ, Zhu J, et al. Kainic acid Induces production and aggregation of amyloid \u03b2-protein and memory deficits by activating inflammasomes in NLRP3- and NF-\u03baB-stimulated pathways. Aging (Albany NY). 2019;11:3795\u2013810.","journal-title":"Aging (Albany NY)"},{"key":"1275_CR171","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","volume":"285","author":"C Juliana","year":"2010","unstructured":"Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu JW, et al. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J Biol Chem. 2010;285:9792\u2013802.","journal-title":"J Biol Chem"},{"key":"1275_CR172","doi-asserted-by":"publisher","first-page":"108913","DOI":"10.1016\/j.intimp.2022.108913","volume":"108","author":"W Ding","year":"2022","unstructured":"Ding W, Cai C, Zhu X, Wang J, Jiang Q. Parthenolide ameliorates neurological deficits and neuroinflammation in mice with traumatic brain injury by suppressing STAT3\/NF-\u03baB and inflammasome activation. Int Immunopharmacol. 2022;108:108913.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR173","doi-asserted-by":"publisher","first-page":"856694","DOI":"10.3389\/fimmu.2022.856694","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang K, Zhang M, Zhang X, Zhang R. Parthenolide suppresses T helper 17 and alleviates experimental autoimmune encephalomyelitis. Front Immunol. 2022;13:856694.","journal-title":"Front Immunol"},{"key":"1275_CR174","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.3390\/molecules19033327","volume":"19","author":"LM Kuo","year":"2014","unstructured":"Kuo LM, Kuo CY, Lin CY, Hung MF, Shen JJ, Hwang TL. Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules. 2014;19:3327\u201344.","journal-title":"Molecules"},{"key":"1275_CR175","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biopha.2015.04.016","volume":"72","author":"J Yang","year":"2015","unstructured":"Yang J, Jiang H, Wang C, Yang B, Zhao L, Hu D, et al. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects. Biomed Pharmacother. 2015;72:125\u201334.","journal-title":"Biomed Pharmacother"},{"key":"1275_CR176","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","volume":"10","author":"A Zahid","year":"2019","unstructured":"Zahid A, Li B, Kombe A, Jin T, Tao J. Pharmacological inhibitors of the NLRP3 inflammasome. Front Immunol. 2019;10:2538.","journal-title":"Front Immunol"},{"key":"1275_CR177","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/ijms17091395","volume":"17","author":"D Li","year":"2016","unstructured":"Li D, Han T, Liao J, Hu X, Xu S, Tian K, et al. Oridonin, a promising ent-kaurane diterpenoid lead compound. Int J Mol Sci. 2016;17:1395.","journal-title":"Int J Mol Sci"},{"key":"1275_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018;9:2550.","journal-title":"Nat Commun"},{"key":"1275_CR179","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41401-022-00995-3","volume":"44","author":"L Li","year":"2023","unstructured":"Li L, Song JJ, Zhang MX, Zhang HW, Zhu HY, Guo W, et al. Oridonin ameliorates caspase-9-mediated brain neuronal apoptosis in mouse with ischemic stroke by inhibiting RIPK3-mediated mitophagy. Acta Pharm Sin. 2023;44:726\u201340.","journal-title":"Acta Pharm Sin"},{"key":"1275_CR180","doi-asserted-by":"publisher","first-page":"e0151397","DOI":"10.1371\/journal.pone.0151397","volume":"11","author":"S Wang","year":"2016","unstructured":"Wang S, Yu L, Yang H, Li C, Hui Z, Xu Y, et al. Oridonin attenuates synaptic loss and cognitive deficits in an A\u03b21-42-induced mouse model of Alzheimer\u2019s disease. PLoS One. 2016;11:e0151397.","journal-title":"PLoS One"},{"key":"1275_CR181","doi-asserted-by":"publisher","first-page":"e104745","DOI":"10.1371\/journal.pone.0104745","volume":"9","author":"S Wang","year":"2014","unstructured":"Wang S, Yang H, Yu L, Jin J, Qian L, Zhao H, et al. Oridonin attenuates A\u03b21-42-induced neuroinflammation and inhibits NF-\u03baB pathway. PLoS One. 2014;9:e104745.","journal-title":"PLoS One"},{"key":"1275_CR182","doi-asserted-by":"publisher","first-page":"114136","DOI":"10.1016\/j.bcp.2020.114136","volume":"180","author":"P Liu","year":"2020","unstructured":"Liu P, Du J. Oridonin is an antidepressant molecule working through the PPAR-\u03b3\/AMPA receptor signaling pathway. Biochem Pharm. 2020;180:114136.","journal-title":"Biochem Pharm"},{"key":"1275_CR183","doi-asserted-by":"publisher","first-page":"112247","DOI":"10.1016\/j.intimp.2024.112247","volume":"134","author":"T Zhao","year":"2024","unstructured":"Zhao T, Zhang X, Cui X, Su S, Li L, Chen Y, et al. Oridonin exerts anticonvulsant profile and neuroprotective activity in epileptic mice by inhibiting NLRP3-mediated pyroptosis. Int Immunopharmacol. 2024;134:112247.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR184","doi-asserted-by":"publisher","first-page":"107358","DOI":"10.1016\/j.intimp.2020.107358","volume":"92","author":"Y Shi","year":"2021","unstructured":"Shi Y, Lv Q, Zheng M, Sun H, Shi F. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages. Int Immunopharmacol. 2021;92:107358.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR185","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/WNR.0000000000002023","volume":"35","author":"H Yi","year":"2024","unstructured":"Yi H, Zhu B, Zheng C, Ying Z, Cheng M. CXCL13\/CXCR5 promote chronic postsurgical pain and astrocyte activation in rats by targeting NLRP3. Neuroreport. 2024;35:406\u201312.","journal-title":"Neuroreport"},{"key":"1275_CR186","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","volume":"91","author":"S Darakhshan","year":"2015","unstructured":"Darakhshan S, Pour AB. Tranilast: a review of its therapeutic applications. Pharm Res. 2015;91:15\u201328.","journal-title":"Pharm Res"},{"key":"1275_CR187","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","volume":"10","author":"Y Huang","year":"2018","unstructured":"Huang Y, Jiang H, Chen Y, Wang X, Yang Y, Tao J, et al. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol Med. 2018;10:e8689.","journal-title":"EMBO Mol Med"},{"key":"1275_CR188","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/neup.12802","volume":"42","author":"H Jia","year":"2022","unstructured":"Jia H, Qi X, Fu L, Wu H, Shang J, Qu M, et al. NLRP3 inflammasome inhibitor ameliorates ischemic stroke by reprogramming the phenotype of microglia\/macrophage in a murine model of distal middle cerebral artery occlusion. Neuropathology. 2022;42:181\u20139.","journal-title":"Neuropathology"},{"key":"1275_CR189","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-021-08675-x","volume":"24","author":"P Thapak","year":"2022","unstructured":"Thapak P, Bishnoi M, Sharma SS. Tranilast, a transient receptor potential vanilloid 2 channel (TRPV2) inhibitor attenuates amyloid \u03b2-induced cognitive impairment: possible mechanisms. Neuromol Med. 2022;24:183\u201394.","journal-title":"Neuromol Med"},{"key":"1275_CR190","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1021\/acschemneuro.0c00339","volume":"11","author":"J Lu","year":"2020","unstructured":"Lu J, Chen C, Deng X, Mak MS, Zhu Z, He X, et al. Design, synthesis, and biological evaluation of novel multifunctional rolipram-tranilast hybrids as potential treatment for traumatic brain injury. ACS Chem Neurosci. 2020;11:2348\u201360.","journal-title":"ACS Chem Neurosci"},{"key":"1275_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1471-y","volume":"16","author":"R Kuwar","year":"2019","unstructured":"Kuwar R, Rolfe A, Di L, Xu H, He L, Jiang Y, et al. A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. J Neuroinflamm. 2019;16:81.","journal-title":"J Neuroinflamm"},{"key":"1275_CR192","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","volume":"55","author":"J Yin","year":"2018","unstructured":"Yin J, Zhao F, Chojnacki JE, Fulp J, Klein WL, Zhang S, et al. NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol. 2018;55:1977\u201387.","journal-title":"Mol Neurobiol"},{"key":"1275_CR193","doi-asserted-by":"publisher","first-page":"893912","DOI":"10.3389\/fimmu.2022.893912","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Ji S, Jiang ML, Xu Y, Zhang CJ. The regulation and modification of GSDMD signaling in diseases. Front Immunol. 2022;13:893912.","journal-title":"Front Immunol"},{"key":"1275_CR194","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","volume":"11","author":"BE Burdette","year":"2021","unstructured":"Burdette BE, Esparza AN, Zhu H, Wang S. Gasdermin D in pyroptosis. Acta Pharm Sin B. 2021;11:2768\u201382.","journal-title":"Acta Pharm Sin B"},{"key":"1275_CR195","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21:736\u201345.","journal-title":"Nat Immunol"},{"key":"1275_CR196","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B, Nemmara VV, et al. Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020;369:1633\u20137.","journal-title":"Science"},{"key":"1275_CR197","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1111\/jcmm.15439","volume":"24","author":"C Han","year":"2020","unstructured":"Han C, Yang Y, Guan Q, Zhang X, Shen H, Sheng Y, et al. New mechanism of nerve injury in Alzheimer\u2019s disease: \u03b2-amyloid-induced neuronal pyroptosis. J Cell Mol Med. 2020;24:8078\u201390.","journal-title":"J Cell Mol Med"},{"key":"1275_CR198","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2020.07.016","volume":"32","author":"A Hooftman","year":"2020","unstructured":"Hooftman A, Angiari S, Hester S, Corcoran SE, Runtsch MC, Ling C, et al. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 2020;32:468\u2013478.e7.","journal-title":"Cell Metab"},{"key":"1275_CR199","doi-asserted-by":"publisher","first-page":"825428","DOI":"10.3389\/fimmu.2022.825428","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Shi K, An N, Li S, Bai M, Wu X, et al. Direct inhibition of GSDMD by PEITc reduces hepatocyte pyroptosis and alleviates acute liver injury in mice. Front Immunol. 2022;13:825428.","journal-title":"Front Immunol"},{"key":"1275_CR200","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1182\/blood.2021011525","volume":"138","author":"CMS Silva","year":"2021","unstructured":"Silva CMS, Wanderley C, Veras FP, Sonego F, Nascimento DC, Gon\u00e7alves AV, et al. Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation. Blood. 2021;138:2702\u201313.","journal-title":"Blood"},{"key":"1275_CR201","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","volume":"119","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang Y, Wang B, Xie C, Wang J, Fang R, et al. Pyroptosis-mediator GSDMD promotes Parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death. Brain Behav Immun. 2024;119:129\u201345.","journal-title":"Brain Behav Immun"},{"key":"1275_CR202","doi-asserted-by":"publisher","first-page":"9253","DOI":"10.1523\/JNEUROSCI.4587-15.2016","volume":"36","author":"M Zhao","year":"2016","unstructured":"Zhao M, Sun D, Guan Y, Wang Z, Sang D, Liu M, et al. Disulfiram and diphenhydramine hydrochloride upregulate miR-30a to suppress IL-17-associated autoimmune inflammation. J Neurosci. 2016;36:9253\u201366.","journal-title":"J Neurosci"},{"key":"1275_CR203","first-page":"126","volume":"31","author":"C Bo","year":"2024","unstructured":"Bo C, Li J, Wang J, Zhang Y, Wu T, Wang M, et al. Dimethyl fumarate modulates the immune environment and improves prognosis in the acute phase after ischemic stroke. Neuroimmunomodulation. 2024;31:126\u201341.","journal-title":"Neuroimmunomodulation"},{"key":"1275_CR204","doi-asserted-by":"publisher","first-page":"eaat2738","DOI":"10.1126\/sciimmunol.aat2738","volume":"3","author":"JK Rathkey","year":"2018","unstructured":"Rathkey JK, Zhao J, Liu Z, Chen Y, Yang J, Kondolf HC, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol. 2018;3:eaat2738.","journal-title":"Sci Immunol"},{"key":"1275_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35975-y","volume":"13","author":"YH Leem","year":"2023","unstructured":"Leem YH, Kim DY, Park JE, Kim HS. Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and \u03b1-synuclein oligomerization in a subacute MPTP mouse model of Parkinson\u2019s disease. Sci Rep. 2023;13:8783.","journal-title":"Sci Rep."},{"key":"1275_CR206","doi-asserted-by":"publisher","first-page":"916249","DOI":"10.3389\/fnmol.2022.916249","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang Y, Wang F, Liu Y, Yong VW, Xue M. Necrosulfonamide Alleviates Acute Brain Injury of Intracerebral Hemorrhage via Inhibiting Inflammation and Necroptosis. Front Mol Neurosci. 2022;15:916249.","journal-title":"Front Mol Neurosci"},{"key":"1275_CR207","doi-asserted-by":"publisher","first-page":"108756","DOI":"10.1016\/j.celrep.2021.108756","volume":"34","author":"M Bambouskova","year":"2021","unstructured":"Bambouskova M, Potuckova L, Paulenda T, Kerndl M, Mogilenko DA, Lizotte K, et al. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 2021;34:108756.","journal-title":"Cell Rep."},{"key":"1275_CR208","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3892\/or.2015.4260","volume":"34","author":"YC Chou","year":"2015","unstructured":"Chou YC, Chang MY, Wang MJ, Yu FS, Liu HC, Harnod T, et al. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression. Oncol Rep. 2015;34:2489\u201396.","journal-title":"Oncol Rep."},{"key":"1275_CR209","doi-asserted-by":"publisher","first-page":"855828","DOI":"10.3389\/fphar.2022.855828","volume":"13","author":"XX Liao","year":"2022","unstructured":"Liao XX, Dai YZ, Zhao YZ, Nie K. Gasdermin E: a prospective target for therapy of diseases. Front Pharm. 2022;13:855828.","journal-title":"Front Pharm"},{"key":"1275_CR210","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"1275_CR211","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.7150\/thno.100090","volume":"14","author":"J Ye","year":"2024","unstructured":"Ye J, Bi X, Deng S, Wang X, Liu Z, Suo Q, et al. Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke. Theranostics. 2024;14:6071\u201387.","journal-title":"Theranostics"},{"key":"1275_CR212","doi-asserted-by":"publisher","first-page":"107789","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107789","volume":"33","author":"M Zhao","year":"2024","unstructured":"Zhao M, Xian W, Liu W, Chen D, Wang S, Cao J. Maresin1 alleviates neuroinflammation by inhibiting caspase-3\/GSDME-mediated pyroptosis in mice cerebral ischemia\u2012reperfusion model. J Stroke Cerebrovasc Dis. 2024;33:107789.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1275_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.11.004","volume":"536","author":"Q Wang","year":"2024","unstructured":"Wang Q, Guo S, Hu D, Dong X, Meng Z, Jiang Y, et al. Enhanced gasdermin-E-mediated pyroptosis in Alzheimer\u2019s disease. Neuroscience. 2024;536:1\u201311.","journal-title":"Neuroscience"},{"key":"1275_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04420-1","volume":"12","author":"PM Soriano-Teruel","year":"2021","unstructured":"Soriano-Teruel PM, Garc\u00eda-La\u00ednez G, Marco-Salvador M, Pardo J, Arias M, DeFord C, et al. Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases. Cell Death Dis. 2021;12:1155.","journal-title":"Cell Death Dis"},{"key":"1275_CR215","doi-asserted-by":"publisher","first-page":"104884","DOI":"10.1016\/j.phrs.2020.104884","volume":"158","author":"Q Liang","year":"2020","unstructured":"Liang Q, Cai W, Zhao Y, Xu H, Tang H, Chen D, et al. Lycorine ameliorates bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and pyroptosis. Pharm Res. 2020;158:104884.","journal-title":"Pharm Res"},{"key":"1275_CR216","doi-asserted-by":"publisher","first-page":"107518","DOI":"10.1016\/j.phrs.2024.107518","volume":"210","author":"J Wen","year":"2024","unstructured":"Wen J, Li Y, Qin Y, Yan L, Zhang K, Li A, et al. Lycorine protects motor neurons against TDP-43 proteinopathy-induced degeneration in cross-species models with amyotrophic lateral sclerosis. Pharm Res. 2024;210:107518.","journal-title":"Pharm Res"},{"key":"1275_CR217","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.apsb.2019.02.003","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, Xu G, Gao Y, Zhan X, Qin N, Fu S, et al. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm Sin B. 2019;9:734\u201344.","journal-title":"Acta Pharm Sin B"},{"key":"1275_CR218","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02682-w","volume":"19","author":"C Chen","year":"2022","unstructured":"Chen C, Zhou Y, Ning X, Li S, Xue D, Wei C, et al. Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. J Neuroinflamm. 2022;19:315.","journal-title":"J Neuroinflamm"},{"key":"1275_CR219","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK. \u03b2-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology. J Neuroinflamm. 2020;17:280.","journal-title":"J Neuroinflamm"},{"key":"1275_CR220","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.3333","volume":"17","author":"H Shi","year":"2016","unstructured":"Shi H, Wang Y, Li X, Zhan X, Tang M, Fina M, et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016;17:250\u20138.","journal-title":"Nat Immunol"},{"key":"1275_CR221","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10787-022-01026-7","volume":"30","author":"J Wang","year":"2022","unstructured":"Wang J, Chen S, Liu M, Zhang M, Jia X. NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases. Inflammopharmacology. 2022;30:1179\u201387.","journal-title":"Inflammopharmacology"},{"key":"1275_CR222","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5582\/bst.2020.01029","volume":"14","author":"G Liu","year":"2020","unstructured":"Liu G, Chen X, Wang Q, Yuan L. NEK7: a potential therapy target for NLRP3-related diseases. Biosci Trends. 2020;14:74\u201382.","journal-title":"Biosci Trends"},{"key":"1275_CR223","doi-asserted-by":"publisher","first-page":"101310","DOI":"10.1016\/j.xcrm.2023.101310","volume":"4","author":"X Jin","year":"2023","unstructured":"Jin X, Liu D, Zhou X, Luo X, Huang Q, Huang Y. Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7. Cell Rep. Med. 2023;4:101310.","journal-title":"Cell Rep. Med"},{"key":"1275_CR224","doi-asserted-by":"publisher","first-page":"e247045","DOI":"10.6004\/jnccn.2024.7045","volume":"22","author":"J Simoneau","year":"2024","unstructured":"Simoneau J, Robertson P, Muraszko K, Maher CO, Garton H, Calvert R, et al. Long-term tumor stability after first-line treatment with larotrectinib in an infant with NTRK2 fusion-positive high-grade glioma. J Natl Compr Canc Netw. 2024;22:e247045.","journal-title":"J Natl Compr Canc Netw"},{"key":"1275_CR225","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1021\/acs.jmedchem.0c01743","volume":"64","author":"Q Zeng","year":"2021","unstructured":"Zeng Q, Deng H, Li Y, Fan T, Liu Y, Tang S, et al. Berberine directly targets the NEK7 protein to block the NEK7-NLRP3 interaction and exert anti-inflammatory activity. J Med Chem. 2021;64:768\u201381.","journal-title":"J Med Chem"},{"key":"1275_CR226","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1002\/iid3.766","volume":"11","author":"MJ Tavaf","year":"2023","unstructured":"Tavaf MJ, Soltanmohammadi A, Zargarani S, Yazdanpanah E, Sadighimoghaddam B, Yousefi B, et al. Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells. Immun Inflamm Dis. 2023;11:e766.","journal-title":"Immun Inflamm Dis"},{"key":"1275_CR227","doi-asserted-by":"publisher","first-page":"124218","DOI":"10.1016\/j.ijpharm.2024.124218","volume":"658","author":"SR Saleh","year":"2024","unstructured":"Saleh SR, Abd-Elmegied A, Aly Madhy S, Khattab SN, Sheta E, Elnozahy FY, et al. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer\u2019s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis. Int J Pharm. 2024;658:124218.","journal-title":"Int J Pharm"},{"key":"1275_CR228","doi-asserted-by":"publisher","first-page":"618787","DOI":"10.3389\/fphar.2020.618787","volume":"11","author":"S Huang","year":"2020","unstructured":"Huang S, Liu H, Lin Y, Liu M, Li Y, Mao H, et al. Berberine protects against NLRP3 inflammasome via ameliorating autophagic impairment in MPTP-induced Parkinson\u2019s disease model. Front Pharm. 2020;11:618787.","journal-title":"Front Pharm"},{"key":"1275_CR229","doi-asserted-by":"publisher","first-page":"e53499","DOI":"10.15252\/embr.202153499","volume":"23","author":"Q Li","year":"2022","unstructured":"Li Q, Feng H, Wang H, Wang Y, Mou W, Xu G, et al. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction. EMBO Rep. 2022;23:e53499.","journal-title":"EMBO Rep."},{"key":"1275_CR230","doi-asserted-by":"publisher","first-page":"108073","DOI":"10.1016\/j.intimp.2021.108073","volume":"100","author":"B Zhou","year":"2021","unstructured":"Zhou B, Wang H, Zhang B, Zhang L. Licochalcone B attenuates neuronal injury through antioxidant effect and enhancement of Nrf2 pathway in MCAO rat model of stroke. Int Immunopharmacol. 2021;100:108073.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR231","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/14786419.2018.1496429","volume":"34","author":"Y Cao","year":"2020","unstructured":"Cao Y, Xu W, Huang Y, Zeng X. Licochalcone B, a chalcone derivative from Glycyrrhiza inflata, as a multifunctional agent for the treatment of Alzheimer\u2019s disease. Nat Prod Res. 2020;34:736\u20139.","journal-title":"Nat Prod Res"},{"key":"1275_CR232","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1063-4584(03)00153-5","volume":"11","author":"K Rudolphi","year":"2003","unstructured":"Rudolphi K, Gerwin N, Verzijl N, van der Kraan P, van den Berg W. Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthr Cartil. 2003;11:738\u201346.","journal-title":"Osteoarthr Cartil"},{"key":"1275_CR233","unstructured":"Boxer MB, Shen M, Auld DS, Wells JA, Thomas CJ. A small molecule inhibitor of Caspase 1, in Probe Reports from the NIH Molecular Libraries Program. 2010, National Center for Biotechnology Information (US): Bethesda (MD)."},{"key":"1275_CR234","doi-asserted-by":"publisher","first-page":"105771","DOI":"10.1016\/j.intimp.2019.105771","volume":"75","author":"H Liang","year":"2019","unstructured":"Liang H, Sun Y, Gao A, Zhang N, Jia Y, Yang S, et al. Ac-YVAD-cmk improves neurological function by inhibiting caspase-1-mediated inflammatory response in the intracerebral hemorrhage of rats. Int Immunopharmacol. 2019;75:105771.","journal-title":"Int Immunopharmacol"},{"key":"1275_CR235","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.bbi.2020.03.011","volume":"87","author":"H Kim","year":"2020","unstructured":"Kim H, Seo JS, Lee SY, Ha KT, Choi BT, Shin YI, et al. AIM2 inflammasome contributes to brain injury and chronic poststroke cognitive impairment in mice. Brain Behav Immun. 2020;87:765\u201376.","journal-title":"Brain Behav Immun"},{"key":"1275_CR236","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41401-024-01257-0","volume":"45","author":"F Wang","year":"2024","unstructured":"Wang F, Wang Y, Zhang QY, Hu KY, Song YJ, Yang L, et al. Small-molecule caspase-1 inhibitor CZL80 terminates refractory status epilepticus via inhibition of glutamatergic transmission. Acta Pharm Sin. 2024;45:1381\u201392.","journal-title":"Acta Pharm Sin"},{"key":"1275_CR237","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/ijms19082155","volume":"19","author":"R Bent","year":"2018","unstructured":"Bent R, Moll L, Grabbe S, Bros M. Interleukin-1 beta-a friend or foe in malignancies? Int J Mol Sci. 2018;19:2155.","journal-title":"Int J Mol Sci"},{"key":"1275_CR238","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00702-017-1732-9","volume":"125","author":"AS Mendiola","year":"2018","unstructured":"Mendiola AS, Cardona AE. The IL-1\u03b2 phenomena in neuroinflammatory diseases. J Neural Transm (Vienna). 2018;125:781\u201395.","journal-title":"J Neural Transm (Vienna)"},{"key":"1275_CR239","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/mabs.2.1.10328","volume":"2","author":"E Dhimolea","year":"2010","unstructured":"Dhimolea E. Canakinumab. MAbs. 2010;2:3\u201313.","journal-title":"MAbs"},{"key":"1275_CR240","first-page":"659","volume":"16","author":"E Giat","year":"2014","unstructured":"Giat E, Lidar M. Cryopyrin-associated periodic syndrome. Isr Med Assoc J. 2014;16:659\u201361.","journal-title":"Isr Med Assoc J"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01275-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01275-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01275-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T18:27:55Z","timestamp":1743359275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01275-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":240,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["1275"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01275-w","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests. RZ is Deputy Editor-in-Chief of Cellular & Molecular Immunology, but he has not been involved in the peer review or the decision-making of the article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}